Strategy characteristics | Considered values |
---|---|
Age to start screening, y | 45*, 55 |
Age to stop screening, y | 75, 77, 80 |
Screening interval | Annual |
| |
Risk-based criteria | Considered values |
| |
Evaluated risk-prediction models | Bach, PLCOm2012, LCDRAT |
Evaluated risk thresholds | 0.9%, 1.0%, 1.1%, 1.2%, 1.3%, |
1.4%, 1.5%, 1.6%, 1.7%, 1.8%, | |
1.9%, 2.0%, 2.1%, 2.2%, 2.3%, | |
2.4%, 2.5%, 2.6%, 2.7%, 2.8%, | |
2.9%, 3.0%, 3.1%, 3.2%, 3.3%, | |
3.4%, 3.5%, 3.6%, | |
†Risk threshold that yielded a similar sensitivity for ever-smokers in the PLCO control arm as the USPSTF criteria (one for each risk-prediction model) | |
‡Risk thresholds that selected a similar proportion of ever-smokers for screening in the PLCO control arm as the USPSTF criteria (one for each risk-prediction model) | |
| |
Non–risk-based strategies | Description |
| |
USPSTF–smoking eligibility criteria | Annual screening for individuals who smoked at least 30 pack-years and currently smoke or quit less than 15 y ago |
The USPSTF criteria was evaluated for screening between age ranges 55–75, 55–77, and 55–80 y | |
|
Considered only for risk-based strategies that stop screening at age 80 y.
Corresponding risk thresholds: PLCOm2012 = 1.83%; Bach = 1.91%; LCDRAT = 1.34%.
Corresponding risk thresholds: PLCOm2012 = 1.36%; Bach = 1.59%; LCDRAT = 0.96%.
LCDRAT = Lung Cancer Death Risk Assessment Tool; PLCO = Prostate Lung, Colorectal, and Ovarian Cancer Screening Trial, USPSTF: United States Preventive Services Task Force.